S100A10 and prostate carcinoma: Our aim was to demonstrate that stroma’s profile could predict the risk to develop prostate cancer and its prognosis, since some molecules secreted by CAFs may induce prostate cancer progression; on these bases, we performed a correlation analysis between SCARB1, MAPK3K1, and S100A10 expression and both clinical pathological characteristics and patient outcomes.